Pradaxa drug capsules

Pradaxa drug capsules

C023/4164 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 51.3MB

Downloadable file size: 3.4MB

Price image Pricing

Please login to use the price calculator


Credit: MARK THOMAS/SCIENCE PHOTO LIBRARY

Restrictions: Editorial use only

Caption: Pradaxa drug capsules. Pradaxa is a trademark for the anticoagulant drug Dabigatran. This drug can be used as an alternative to drugs such as warfarin and heparin, with typical uses being to prevent clots during surgery and in stroke patients. Dabigatran was developed by multinational German pharmaceutical company Boehringer Ingelheim. It was approved in Europe and the USA in 2008 and 2010.

Release details: Model release not required. Property release not required.

Keywords: 110 mg, 110mg, 150 mg, 150mg, 2014, 21st century, 75 mg, 75mg, anti thrombosis, anticoagulant, antithrombotic, blood thinner, boehringer ingelheim, capsule, capsules, close-up, clot preventing, clot prevention, dabigatran, dabigatran etexilate, detail, drug, hard capsules, medical, medicine, no-one, nobody, oral, oral use, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pill, pills, pradaxa, prescribed, prescription, registered trademark, still life, still-life, stroke prevention, studio shot, thinning

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.